PROTALIX BIOTHERAPEUTICS INC - COM (PLX)

CUSIP: 74365A101

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class
Equity / COM
Total 13F shares
24,210,252
Share change
-1,048,740
Total reported value
$15,495,000
Price per share
$0.64
Number of holders
22
Value change
-$700,302
Number of buys
5
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 74365A101?
CUSIP 74365A101 identifies PLX - PROTALIX BIOTHERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PROTALIX BIOTHERAPEUTICS INC - COM (PLX) as of Q2 2016

As of 30 Jun 2016, PROTALIX BIOTHERAPEUTICS INC - COM (PLX) was held by 22 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 24,210,252 shares. The largest 10 holders included Camber Capital Management LLC, BAILLIE GIFFORD & CO, Broadfin Capital, LLC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, BARCLAYS PLC, DEUTSCHE BANK AG\, BRIDGEWAY CAPITAL MANAGEMENT INC, BlackRock Group LTD, RENAISSANCE TECHNOLOGIES LLC, and Spark Investment Management LLC. This page lists 22 institutional shareholders reporting positions in this security for the Q2 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.